¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"technetium Tc 99m pyrophosphate imaging"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® magnetic resonance imaging(MRI) ÇÑ±Û ÀÚ±â°ø¸í¿µ»ó
¼³¸í   
  ÀÎüÀÇ Àå±â³ª, º´ÀûÀΠ¸ð¾ç, Á¾¾çÀÇ À§Ä¡, ¸²ÇÁÀýÀÇ ºñ´ë µî¿¡ ´ëÇÑ Áø´ÜÀ» ³»¸®±â À§ÇØ ½ÃÇàÇϴ ¹æ»ç¼±ÇÐÀûÀΠ°Ë»ç¹æ¹ýÀÌ´Ù. ÇöÀç ¸¹ÀÌ ¾²À̰í Àִ ÄÄÇ»ÅÍ´ÜÃþÃÔ¿µ¼ú(CT: computerized tomography)°ú´Â ´Ù¸¥ ¹æ¹ýÀ¸·Î ½ÃÇàÇϸç, ±× Çػ󵵰¡ ÄÄÇ»ÅÍ´ÜÃþÃÔ¿µº¸´Ù´Â ¶Ù¾î³ª ºñ·Ï °í°¡À̱ä ÇÏÁö¸¸, ¸¹ÀÌ ¾²À̰í ÀÖ´Ù. ¶ÇÇÑ ÀÎü¿¡ ¹«ÇØÇϰí, ¿©·¯ °¡Áö ¸é¿¡¼­ »ç¶÷À» ´ÜÃþÀ¸·Î ºÐ¸®½ÃÄÑ º¼ ¼ö Àִ µî ÀåÁ¡ÀÌ ¸¹´Ù. ´ÜÁ¡Àº ½ÉÀå¹Úµ¿±â¸¦ ¼³Ä¡ÇÑ »ç¶÷À̳ª, ÁÖÀ§¿¡ ÀåÀ» ¶ì´Â ¹°Ã¼¸¦ ¸ö¿¡ Áö´Ï°í Àִ ÁßȯÀÚ µî¿¡¼­´Â ÀÌ¿ëÇÒ ¼ö ¾ø°í, º¹ºÎÀå±â¿¡ ´ëÇÑ Áø´Ü¿¡´Â ÄÄÇ»ÅÍ´ÜÃþÃÔ¿µº¸´Ù ºÒ¸®ÇÑ °ÍÀ¸·Î µÇ¾î ÀÖÀ¸¸ç, ¹«¾ùº¸´Ù ¼³Ä¡ºñ¿Í ±× ½Ã¼úºñ°¡ ºñ½Î´Ù´Âµ¥ °¡Àå Å« ´ÜÁ¡ÀÌ ÀÖ´Ù.
  
  
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • pyrophosphate
    ÇÇ·ÎÀλ꿰
  • technetium
    Å×Å©³×Ƭ
  • adjunctive imaging technique
    º¸Á¶¿µ»ó±â¹ý
  • cine magnetic resonance imaging
    ¿µÈ­ÀÚ±â°ø¸í¿µ»ó
  • chemical shift imaging
    È­Çк¯À§¿µ»ó
  • dynamic imaging
    ¿ªµ¿¿µ»ó, µ¿¿µ»ó
  • diffusion tensor imaging
    È®»êÅÙ¼­¿µ»ó
  • diffusion weighted imaging
    È®»ê°­Á¶¿µ»ó
  • fast imaging technique
    °í¼Ó¿µ»ó±â¹ý
  • frequency modulation imaging
    Á֯ļöº¯Á¶¿µ»ó
  • functional magnetic resonance imaging
    ±â´ÉÀÚ±â°ø¸í¿µ»ó¹ý
  • gradient acquisition imaging
    ±â¿ï±âȹµæ¿µ»ó
  • gradient echo imaging
    ±â¿ï±â¿¡ÄÚ¿µ»ó
  • gradient refocused imaging
    ±â¿ï±âÀçÃÊÁ¡¿µ»ó
  • hybrid imaging
    È¥ÇÕ¿µ»ó
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • pyrophosphate
    ÇÇ·ÎÀλ꿰
  • technetium
    Å×Å©³×Ƭ
  • imaging
    1. ¿µ»ó, Á¶¿µ, 2. »ó»ó
  • magnetic resonance imaging
    ÀÚ±â°ø¸í¿µ»ó
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • pyrophosphate
    ÇÇ·ÎÀλ꿰
  • technetium
    Å×Å©³×Ƭ
  • adjunctive imaging technique
    º¸Á¶¿µ»ó±â¹ý
  • multislice imaging acquisition
    ´ÙÁßÀýÆí¿µ»óȹµæ
  • chemical shift imaging
    È­Çк¯À§¿µ»ó
  • cine magnetic resonance imaging
    ¿µÈ­ÀÚ±â°ø¸í¿µ»ó
  • diffusion tensor imaging
    È®»êÅÙ¼­¿µ»ó
  • diffusion weighted imaging
    È®»ê°­Á¶¿µ»ó
  • dynamic imaging
    ¿ªµ¿¿µ»ó, µ¿¿µ»ó
  • fast imaging technique
    °í¼Ó¿µ»ó±â¹ý
  • frequency modulation imaging
    Á֯ļöº¯Á¶¿µ»ó
  • gradient acquisition imaging
    ±â¿ï±âȹµæ¿µ»ó
  • gradient echo imaging
    ±â¿ï±â¿¡ÄÚ¿µ»ó
  • gradient refocused imaging
    ±â¿ï±âÀçÃÊÁ¡¿µ»ó
  • imaging gradient
    ¿µ»ó±â¿ï±â
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • phosphoribosyl pyrophosphate synthetase
    Æ÷½ºÆ÷¸®º¸½ÇÇÇ·ÎÆ÷½ºÆäÀÌÆ®½ÅÅןÁ¦<ÇÕ¼ºÈ¿¼Ò>
  • pyrophosphate
    ÆÄÀÌ·ÎÀλ꿰.
  • Cine-CT cardiac imaging
    ½ÉÀå Àü»êÈ­ ´ÜÃþ ¿µÈ­»ó
  • Fourier imaging
    Fourier(Ǫ¸®¾î) ¿µ»ó
  • MR imaging guided
    ÀÚ±â°ø¸í¿µ»ó À¯µµÇÏ
  • MRI = Magnetic resonance imaging
    ÀÚ±â°ø¸í¿µ»ó(í¸Ñ¨ÍìÙ°ç±ßÀ)
  • Magnetic resonance imaging = MRI
    ÀÚ±â°ø¸í¿µ»ó(í¸Ñ¨ÍìÙ°ç±ßÀ)(í¸Ñ¨ÍöÙ¢ç±ßÀ)
  • T1 weighted FLASH imaging
    T1 °­Á¶ FLASH ¿µ»ó
  • Zebra-stripe imaging method
    ¾ó·è¸» ¹«´Ì ¿µ»ó ¹æ¹ý
  • adjunctive imaging technique
    º¸Á¶ ¿µ»ó ±â¹ý
  • advanced Fourier imaging
    Áøº¸ Fourier ¿µ»ó
  • fractional echo imaging
    ºÐÇÒ ¿¡ÄÚ ¿µ»ó
  • frequency modulation imaging
    Á֯ļö º¯Á¶ ¿µ»ó
  • functional brain imaging
    ±â´ÉÀû ³ú¿µ»ó
  • functional magnetic resonance imaging (fMRI)
    ±â´ÉÀû ÀÚ±â°ø¸í¿µ»ó
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • technetium-99m compound
    Å×Å©³×½·-99m È­ÇÕ¹°
  • calcium pyrophosphate crystal deposition
    Ä®½·ÇÇ·ÎÀλ꿰 °áÁ¤Ä§Âø(¡­×òß«ç¤ Ì¿ïÜöØó·)
  • lipothiamide pyrophosphate
    ÇÇ·ÎÀλ긮Æ÷Ƽ¾Æ¹Ìµå.
  • phosphoribosyl pyrophosphate synthetase
    Æ÷½ºÆ÷¸®º¸½ÇÇÇ·ÎÆ÷½ºÆäÀÌÆ®½ÅÅןÁ¦<ÇÕ¼ºÈ¿¼Ò>
  • pyrophosphate
    ÆÄÀÌ·ÎÀλ꿰.
  • thiamine pyrophosphate
    ÇÇ·ÎÀλê(¡­ìÝß«)Ƽ¾Æ¹Î.
  • thiamine pyrophosphate
    ÇÇ·ÎÀÎ»êÆ¼¾Æ¹Î, ÆÄÀÌ·ÎÀλêŸÀ̾ƹÎ
  • adjunctive imaging technique
    º¸Á¶ ¿µ»ó ±â¹ý
  • advanced Fourier imaging
    Áøº¸ Fourier ¿µ»ó
  • bistable imaging
    À̰èÁ¶¿µ»ó, ÀÌ»öµµ¿µ»ó
  • black blood imaging
    ÈæÇ÷·ù ¿µ»ó
  • bright blood imaging
    ¸íÇ÷·ù ¿µ»ó
  • cardiac imaging
    ½É(Àå)¿µ»ó(ãýíôç¯ßÀ)
  • chemical shift imaging (CSI)
    È­ÇÐÀû º¯À§ ¿µ»ó
  • cine cardiac magnetic resonance imaging
    ½ÉÀå ¿µÈ­ ÀÚ±â°ø¸í¿µ»ó
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • active pyrophosphate
    Ȱ¼º(üÀàõ)ÇÇ·ÎÀλ꿰 (×òß«ç¤)
  • inorganic pyrophosphate
    ¹«±â(ÙíѦ) ÆÄÀÌ·ÎÀλê(×òß«)
  • ¥á-5-phosphoribosyl-1-pyrophosphate
    ¥á-5-Æ÷½ºÆ÷¶óÀ̺¸½Ç-1-ÇÇ·ÎÀλê(×òß«)
  • pyrophosphate
    ÆÄÀÌ·ÎÀλê(×òß«)
  • pyrophosphate cleavage
    ÆÄÀÌ·ÎÀλê(×òß«) ºÐÇØ(ÝÂú°)
  • pyrophosphate exchange
    ÆÄÀÌ·ÎÀλê(×òß«) ±³È¯(Îßüµ)
  • thiamine pyrophosphate
    ŸÀ̾ƹΠÇÇ·ÎÀλê (ìÝß«)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • adjunctive imaging technique
    º¸Á¶¿µ»ó±â¹ý
  • advanced Fourier imaging
    Áøº¸Fourier¿µ»ó
  • black blood imaging
    ÈæÇ÷·ù¿µ»ó
  • bright blood imaging
    ¸íÇ÷·ù¿µ»ó
  • chemical shift imaging [=CSI]
    È­ÇÐÀûº¯À§¿µ»ó
  • cine cardiac magnetic resonance imaging
    ¿µÈ­½ÉÀåÀÚ±â°ø¸í¿µ»ó
  • color flow imaging
    »öÇ÷·ù¿µ»ó
  • diagnostic imaging
    Áø´ÜÀû¿µ»ó, ¿µ»óÁø´Ü
  • diffusion imaging
    È®»ê¿µ»ó
  • diffusion tensor imaging [=DTI]
    È®»êÅÙ¼­¿µ»ó
  • diffusion weighted imaging [=DWI]
    È®»ê°­Á¶¿µ»ó
  • dynamic imaging
    ¿ªµ¿Àû¿µ»ó
  • echo planar imaging [=EPI]
    ¿¡ÄÚÆò¸é¿µ»ó
  • electrocardiograpic gated magnetic resonance imaging
    ½ÉÀüµµµ¿±âÀÚ±â°ø¸í¿µ»ó
  • fast Fourier imaging
    °í¼ÓFourier¿µ»ó
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
Tc 99m technetium-99m
Tc 99m MDP technetium-99m methylene diphosphonate
TEPP tetraethyl pyrophosphate; triethylene pyrophosphate
DTI dipyridamole-thallium imaging; Doppler tissue imaging
EPI echo planar imaging; electronic portal imaging; Emotion Profile Index; epilepsy; epinephrine; epithe...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
Tc-99m PYP Technetium-99m pyrophosphate
Tc-PYP Technetium 99m pyrophosphate
Tc-99m Technetium 99m
Tc-99m-HMPAO Technetium 99m-hexamethylpropyleneamineoxime
Tc-99m MDP Technetium-99m Methylene Diphosphonate
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • technetium-99m stannous pyrophosphate scintigraphy
    ÆÄÀÌ·Î ÀÎ»ê ¼¶±¤ Á¶¿µ¼ú
  • technetium
    Å×Å©³×Ƭ
    ±Ý¼Ó Àΰø ¹æ»ç¼º ¿ø¼Ò. ¿øÀÚ ¹øÈ£ 43, ¿øÀÚ·® 99. ¿ø¼Ò ±âÈ£ Tc. ´õ¿í ¾ÈÁ¤¼ºÀÇ µ¿À§ ¿ø¼Ò´Â Å×Å©³×Ƭ 99ÀÌ´Ù.
  • calcium pyrophosphate dihydrate
    À̼öÈ­ ÇÇ·ÎÀλê Ä®½·
  • pyrophosphate
    ÇÇ·ÎÀλ꿰
  • advanced Fourier imaging
    Áøº¸ Fourier ¿µ»ó
  • black blood imaging
    ÈæÇ÷·ù ¿µ»ó
  • cine cardiac magnetic resonance imaging
    ¿µÈ­ ½ÉÀå Àڱ⠰ø¸í ¿µ»ó
  • color flow imaging
    »öÇ÷·ù ¿µ»ó
  • diagnostic imaging
    Áø´Ü ¿µ»ó, Áø´Ü ¿µ»ó¼ú, ¿µ»ó Áø´Ü, ¿µ»ó Áø´ÜÇÐ, Áø´ÜÀû ¿µ»ó, Áø´ÜÀû ¿µ»ó»ó
  • direct sagittal CT imaging
    Á÷Á¢ ½Ã»ó¸é ÄÄÇ»ÅÍ ´ÜÃþ ÃÔ¿µ »ó
  • discomfort with this imaging method
    ÃÔ¿µ½Ã ºÒÆí°¨
  • fast Fourier imaging
    °í¼Ó Fourier ¿µ»ó
  • fast imaging with steady state precession
    Ç×Á¤ »óÅ ¼¼Â÷ ¿îµ¿À» ÀÌ¿ëÇÑ °í¼Ó ¿µ»ó
  • fast scan imaging
    °í¼Ó ½ºÄµ ¿µ»ó
  • fractional echo imaging
    ºÐÇÒ ¿¡ÄÚ ¿µ»ó
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
technetium tc 99m pyrophosphate <chemical> A radionuclide imaging agent used primarily in scintigraphy or tomography of the heart to evaluate the extent of the necrotic myocardial process. It has also been used in noninvasive tests for the distribution of organ involvement in different types of amyloidosis and for the evaluation of muscle necrosis in the extremities.
Pharmacological action: radiopharmaceuticals,
(12 Dec 1998)
technetium-99m A radioisotope of technetium which decays by isomeric transition, emitting an essentially monoenergetic gamma ray of 142 keV with a half-life of 6.01 hr. It is usually obtained from a radionuclide generator of molybdenum-99 and is used to prepare radiopharmaceuticals for scanning the brain, parotid, thyroid, lungs, blood pool, liver, heart, spleen, kidney, lacrimal drainage apparatus, bone, and bone marrow.
99mTc diphosphonate, a radionuclide complex used for bone scans.
99mTc-DPTA, a radionuclide chelate complex used for renal imaging and function testing.
99mTc sulfur colloid, a particulate radionuclide complex taken up by the reticuloendothelial system; used for imaging the liver and spleen.
(05 Mar 2000)
technetium tc 99m aggregated albumin <chemical> A gamma-emitting radionuclide imaging agent used for the diagnosis of diseases in many tissues, particularly in cardiovascular and cerebral circulation.
Pharmacological action: radiopharmaceuticals.
(12 Dec 1998)
technetium tc 99m diethyl-iminodiacetic acid <chemical> A nontoxic radiopharmaceutical that is used in the clinical evaluation of hepatobiliary disorders in humans.
Pharmacological action: radiopharmaceuticals.
(12 Dec 1998)
technetium tc 99m dimercaptosuccinic acid <chemical> A nontoxic radiopharmaceutical that is used in the diagnostic imaging of the renal cortex.
Pharmacological action: radiopharmaceuticals.
(12 Dec 1998)
technetium tc 99m disofenin <chemical> A radiopharmaceutical used extensively in cholescintigraphy for the evaluation of hepatobiliary diseases.
Pharmacological action: radiopharmaceuticals.
(12 Dec 1998)
technetium tc 99m exametazime <chemical> A gamma-emitting radionuclide imaging agent used in the evaluation of regional cerebral blood flow and in non-invasive dynamic biodistribution studies and myocardial imaging. It has also been used to label leukocytes in the investigation of inflammatory bowel diseases.
Pharmacological action: radiopharmaceuticals.
(12 Dec 1998)
technetium tc 99m lidofenin <chemical> A nontoxic radiopharmaceutical that is used in the clinical evaluation of hepatobiliary disorders in humans. (j nucl med 1977;18(10):997-1004)
Pharmacological action: radiopharmaceuticals.
(12 Dec 1998)
technetium tc 99m medronate <chemical> A gamma-emitting radionuclide imaging agent used primarily in skeletal scintigraphy. Because of its absorption by a variety of tumours, it is useful for the detection of neoplasms.
Pharmacological action: radiopharmaceuticals.
(12 Dec 1998)
technetium tc 99m mertiatide <chemical> A technetium diagnostic aid used in renal function determination.
Pharmacological action: radiopharmaceuticals.
Chemical name: Technetate(2-)-99Tc, (N-(N-(N-(mercaptoacetyl)glycyl)glycyl)glycinato(5-)-N,N',N'',S)oxo-, disodium, (SP-5-25)-
(12 Dec 1998)
technetium tc 99m pentetate <chemical> A technetium imaging agent used in renal scintigraphy, computed tomography, lung ventilation imaging, gastrointestinal scintigraphy, and many other procedures which employ radionuclide imaging agents.
Pharmacological action: chelating agents, radiopharmaceuticals.
Chemical name: Technetate(1-)-99Tc, (N,N-bis(2-(bis(carboxymethyl)amino)ethyl)glycinato(5-))-, sodium
(12 Dec 1998)
technetium tc 99m sestamibi <chemical> (oc-6-11)-hexakis(1-isocyano-2-methoxy-2-methylpropane)technetium(1+)-99mtc. A technetium imaging agent used to reveal blood-starved cardiac tissue during a heart attack.
Pharmacological action: radiopharmaceuticals.
Chemical name: Technetium(1+)-99Tc, hexakis(1-isocyano-2-methoxy-2-methylpropane)-, (OC-6-11)-
(12 Dec 1998)
technetium tc 99m sulfur colloid <chemical> A gamma-emitting radionuclide imaging agent used for the diagnosis of diseases in many tissues, particularly in the gastrointestinal system, liver, and spleen.
Pharmacological action: radiopharmaceuticals.
(12 Dec 1998)
sodium pertechnetate tc 99m <chemical> A gamma-emitting radionuclide imaging agent used for the diagnosis of diseases in many tissues, particularly in the gastrointestinal system, cardiovascular and cerebral circulation, brain, thyroid, and joints.
Pharmacological action: radiopharmaceuticals.
Chemical name: Technetate (99TcO41-), sodium, (T-4)-
(12 Dec 1998)
technetium <radiology> Tc-99m, half-life: 6.03 hr, decay: isomeric transition, radiation: gamma, 140 keV (98%)
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • imaging radar
    (±º)¿µ»ó;È­»ó·¹ÀÌ´õ
  • technetium
    Å×Å©³×Ƭ(Àΰø ¿ø¼Ò,±âÈ£ Tc)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á